l-Tryptophan-Induced Vasodilation Is Enhanced in Preeclampsia: Studies on Its Uptake and Metabolism in the Human Placenta.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 2 6 2020
medline: 14 4 2021
entrez: 2 6 2020
Statut: ppublish

Résumé

l-tryptophan induces IDO (indoleamine 2,3-dioxygenase) 1-dependent vasodilation. IDO1 is expressed in placental endothelial cells and downregulated in preeclampsia. Hypothesizing that this may contribute to diminished placental perfusion, we studied l-tryptophan-induced vasodilation in healthy and early-onset preeclampsia placental arteries, focusing on placental kynurenine pathway alterations. Despite IDO1 downregulation, kynurenine pathway metabolite concentrations (measured with ultra-performance liquid chromatography-tandem mass spectrometry) were unaltered in preeclamptic versus healthy placentas. Most likely, this is due to enhanced l-tryptophan uptake, evidenced by increased l-tryptophan levels in preeclamptic placentas. Ex vivo perfused cotyledons from healthy and preeclamptic placentas released similar amounts of l-tryptophan and kynurenine pathway metabolites into the circulations. This release was not altered by adding l-tryptophan in the maternal circulation, suggesting that l-tryptophan metabolites act intracellularly. Maternally applied l-tryptophan did appear in the fetal circulation, confirming placental passage of this essential amino acid. After in vitro incubation of placental arteries with IDO1-upregulating cytokines interferon-γ and tumor necrosis factor-α, l-tryptophan induced vasodilation. This vasodilation was attenuated by both IDO1 and nitric oxide (NO) synthase inhibitors. Despite IDO1 downregulation, l-tryptophan-induced relaxation was enhanced in preeclamptic versus healthy placental arteries. However, cytokine stimulation additionally upregulated the LAT (l-type amino acid transporter) 1 in preeclamptic placental arteries only. Vasodilation to the lipophilic, transporter independent ethyl ester of l-tryptophan was reduced in preeclamptic versus healthy placental arteries, in agreement with reduced IDO1 expression. In conclusion, l-tryptophan induces IDO1- and NO-dependent relaxation in placental arteries, which is determined by l-tryptophan uptake rather than IDO1 expression. Increased l-tryptophan uptake might compensate for reduced IDO1 expression in preeclamptic placentas.

Identifiants

pubmed: 32475317
doi: 10.1161/HYPERTENSIONAHA.120.14970
doi:

Substances chimiques

Carrier Proteins 0
Cytokines 0
IDO1 protein, human 0
Indoleamine-Pyrrole 2,3,-Dioxygenase 0
RNA, Messenger 0
Nitric Oxide 31C4KY9ESH
Kynurenine 343-65-7
tryptophan ethyl ester 6519-66-0
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid 76898-47-0
Tryptophan 8DUH1N11BX
Nitric Oxide Synthase EC 1.14.13.39

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

184-194

Auteurs

Michelle Broekhuizen (M)

From the Division of Neonatology, Department of Pediatrics (M.B., E.H., P.S., I.K.M.R.).
Division of Pharmacology and Vascular Medicine, Department of Internal Medicine (M.B., E.H., A.H.J.D.).
Division of Experimental Cardiology, Department of Cardiology (M.B., D.M.).

Theo Klein (T)

Department of Clinical Chemistry (T.K., Y.B.d.R.).

Emilie Hitzerd (E)

From the Division of Neonatology, Department of Pediatrics (M.B., E.H., P.S., I.K.M.R.).
Division of Pharmacology and Vascular Medicine, Department of Internal Medicine (M.B., E.H., A.H.J.D.).

Yolanda B de Rijke (YB)

Department of Clinical Chemistry (T.K., Y.B.d.R.).

Sam Schoenmakers (S)

Department of Obstetrics and Gynecology (S.S.).

Peter Sedlmayr (P)

From the Division of Neonatology, Department of Pediatrics (M.B., E.H., P.S., I.K.M.R.).

A H Jan Danser (AHJ)

Division of Pharmacology and Vascular Medicine, Department of Internal Medicine (M.B., E.H., A.H.J.D.).

Daphne Merkus (D)

Division of Experimental Cardiology, Department of Cardiology (M.B., D.M.).
Erasmus University Medical Center, Rotterdam, the Netherlands, Walter Brendel Center of Experimental Medicine (WBex), LMU Munich, Munich, Germany (D.M.).

Irwin K M Reiss (IKM)

From the Division of Neonatology, Department of Pediatrics (M.B., E.H., P.S., I.K.M.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH